Clinical Trials Directory

Trials / Unknown

UnknownNCT06180239

Segmentectomy vs Lobectomy

Different Segmentectomy vs Lobectomy Comparison in NSCLC

Status
Unknown
Phase
Study type
Observational
Enrollment
800 (estimated)
Sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Actual indications for stage Ia NSCLC patients suggest lobectomy and lymphadenectomy. On the other hand, recent studies reported non-inferiority of segmentectomy in case of nodule \< 2cm or with ground glass appearance at computed tomography. However, most of these studies did not report specifical analysis on kind of segmentectomy (single or multiple) and kind of lobectomy. Moreover, a specific study on solid nodules only is still missing. For these reasons, the effectiveness of segmentectomy instead lobectomy for every kind of segment or tumor is still to be defined. Aim of this study is to analyze survival outcome in patients underwent single or multiple segmentectomy compared to lobectomy in stage I non small cell lung cancer.

Conditions

Timeline

Start date
2017-01-01
Primary completion
2022-12-31
Completion
2024-12-31
First posted
2023-12-22
Last updated
2023-12-22

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT06180239. Inclusion in this directory is not an endorsement.